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A service evaluation of the Eczema Education Programme: an analysis of child, parent and 
service impact outcomes  
Abstract  
Background: The systematic support of parents of children with eczema is essential to their 
effective management. The few existing support models have a limited evidence base. This 
paper reports the outcome-orientated service evaluation of an original, extensive social 
learning theory based, nurse-led Eczema Education Programme (EEP). 
Objectives: To evaluate the EEP using specified child and parental outcomes and service 
impact data.  
Methods: From a sample of 257 parent-child dyads attending the EEP, a pretest-posttest 
design evaluated its child impact using health related quality of life measures (Infant’s 
Dermatitis Quality of Life index, IDQOL, which includes a small dermatitis severity element; 
Children’s Dermatology Life Quality Index, CDLQI), severity measures (Patient Orientated 
Eczema Measure, POEM), a new parental measure (Parental Self-Efficacy in Eczema Care 
Index, PASECI) and service impact data based on General Practice (GP) attendance patterns 
pre-post intervention.  
Results: Statistically significant impacts were observed, compared to baseline, on infant 
quality of life (p<0.001), child quality of life (p=0.027), disease severity (p<0.001) and 
parental self-efficacy (p<0.001). Improvements in child quality of life, parental efficacy and 
service impact were also evident from qualitative data. The cumulative total of all GP visits 
for selected participants post EEP reduced by 62%. 
Conclusions: The EEP appears to be an effective model of delivering structured education to 
parents of children with eczema and one generalizable to other multi-ethnic metropolitan 
populations. As a non-controlled study, this rigorous service evaluation highlights the 
model’s significance and the case for an evaluative multi-centre randomised controlled trial 
of this educational intervention to inform a nurse-led programme of care. 
Introduction  
Atopic dermatitis is a common chronic inflammatory dermatosis affecting approximately 
20% of children 6-7 years in the UK and US 1. Epidemiological evidence suggests varying 
prevalence across countries and ethnic groups within populations 2. It can significantly 
impact on the quality of life for both child and family 3 and frequently leads to healthcare 
consultations 4.  It is predominantly diagnosed and treated in the community 5 and managed 
by parents at home. Access to reliable, disease-specific information to support self-
management is infrequent with parents often receive conflicting information from 
professionals 6. 
Health policy advocates support for self-management of people with long-term skin 
conditions 7. There are examples of nurse-led clinics that have delivered education more 
systematically in primary and secondary care 8; however, their evaluation is limited. A 
Cochrane review, now being updated, revealed few robust trials evaluating education 
interventions for child eczema, with some evidence for two models, multidisciplinary team-
led education and nurse-led delivery 9. There is currently no consensus on the optimal 
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models for supporting parents of children with eczema 4. There is therefore a need for a 
systematic educational approach to enhance treatment adherence and parental support 9, 
10. This is the largest scale structured educational programme targeted at parents 
implemented in the UK and one the largest in Europe. 
The focus of this paper is on the programme’s evaluation of this nurse–led educational 
model in relation to the impact on child, parental and service-related outcomes. 
Materials and Methods  
The study aim was to build up an accurate picture of the roll out, feasibility, implementation 
and impact of the EEP intervention as part of a care pathway for children with eczema, with 
a focus on impact evaluation.  The intervention comprised 3 x 2-hour structured 
community-based nurse-led group education sessions developed by a group of 
practitioners, researchers and educationalists. A ‘tool kit’ provided structure and timings for 
each session creating a consistent approach. The initial trainer model was an expertise 
cascade service delivery model11, involving a specialist nurse training and mentoring 23 
community based practitioners to deliver the programme locally. Eleven of the nurses (EEP 
trainers) began delivering programmes. As attrition rates were high due to competing 
priorities of community staff and acknowledgement of the high level of dermatological 
expertise required to deliver the sessions confidently this model was discontinued and 
replaced with specialist nurse delivery, by one of three specialist dermatology nurses. Table 
1 summarises the content and theoretical base of the programme the content of which is 
close to recently published international recommendations12.  
An evaluative strategy was designed based on a pragmatic methodological approach 13 to 
meet the funding body’s request for a rigorous service evaluation. Validated tools were used 
to measure disease related quality of life and disease severity, and a newly developed tool 
measured parental self-efficacy. Service impact was assessed through review of General 
Practitioner (GP) records. Qualitative data were collected from parent focus groups. Validity 
was enhanced through triangulation of quantitative and qualitative data. National Health 
Service (NHS) research ethics and governance approval was secured.  
A purposive sample, based on a knowledge of the population and the purpose of a study, 
(n= 257 parent-child dyads) was obtained by inviting all who attended the programme 
during the study period (n=356) to participate; this includes children with an eczema 
diagnosis. The study took place in a large inner city UK metropolitan borough with high 
levels of mobility, ethnic diversity and social deprivation (the 29th most deprived in 
England), despite having a proportion of more wealthy families 14. It is acknowledged that 
this group may not be entirely representative of the common profile of eczema families 
which is higher middle class15 however, it does present it own challenges. Data were 
collected in the community based EEP delivery sites (eg: Children’s and health centres) and 
by post for follow-up questionnaires. Evaluation data collection focused on the first year of 
programme delivery, employing quantitative questionnaire and qualitative focus group 
data.  Table 2 provides an overview of data collection and its relationship to the key 
evaluative quantitative outcome measures. The child outcomes were rated by the parents.  
The aim was to obtain a purposive sample of 144 parent-child dyads; that is, 60% of the 240 
available parent-child participants within the first EEP year. This sample was feasible within 
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resources and was calculated to have the power to detect a standardised effect size of 0.27 
based on a two-sided paired t-test at the 5% level with 90% power. There were 
uncertainties in the likely recruitment from this diverse and transient population. 
Completeness of data varied by outcome measure (outlined below).  
 
Due to initial low response rates, the questionnaire survey data were collected over an 
extended 20-month period from parents who attended the EEP between June 2009 and 
January 2011 (n=356). A representative sample (72%, n=257) responded which constitutes 
the core evaluative sample.  Although participants were sent reminders, participation was 
lower at follow-up.  Figure 1 summarises numbers in the sample at each stage of data 
collection/analysis. 
 
The focus group sample was recruited using the inclusion criteria of those eligible for EEP 
referral.  Four audio taped focus groups lasting 45-60 minutes were conducted, involving on 
average 5 parents who had attended the EEP. Twenty mothers and one father participated 
(n=21). Participants, where possible, were purposively selected for maximum variation such 
as child age and ethnicity. Questions focused on parental experience of the EEP and its 
intended outcomes; these were informed by the preliminary analysis of the questionnaire 
data. Data collection continued until saturation was achieved; that is, no new themes 
emerged.  
For the service impact review a purposive sample of children (n=87) with eczema whose 
parents had attended the EEP was identified through the database.  Selection criteria 
were applied, namely, one of the child's parents had completed a minimum of two EEP 
sessions (including one between June 2009 and May 2010) and that their child was 
registered with a local GP. Data were generated through review of GP records from 23 of 53 
participating practices. Resource limitations focused selection pragmatically on the highest 
referrers. The frequencies of direct consultations with the GP or practice nurse for an 
eczema-related complaint were recorded for 8 months pre and post the EEP intervention 
after first attendance.   
Predictive Analytics Software (PASW) 21 was used to analyse the child and parent outcomes.  
This included the summed total scores for: IDQOL 17 (<4 year olds), CDLQI 16 (4-16 year olds), 
POEM 18 (0-16 year olds) (tool employed later in the study), dermatitis severity (<4 year 
olds) and PASECI (parents) 19. Higher scores indicated worse outcomes for each of the 
measures, except PASECI where the reverse was true. To achieve a more meaningful scale 
for the PASECI, the summed scores for this variable were divided by ten. The pre minus post 
intervention score differences were computed for all the measures except for PASECI, 
where the reverse was carried out since higher values indicate higher self-efficacy. Cases 
with complete pre-post data for each measure were selected so the analyses were based on 
variable sample sizes (Fig. 1).  Although the individual items for each measure were 
summed, they were still treated as ordinal.  Following Bland’s guidance 22, Sign tests were 
used to investigate pre-test post-test differences.  However, findings were consistent using 
paired t-tests, when treating the data as interval, which is how they were considered when 
determining the effect size that could be detected from the feasible sample size. Service 
impact data were analysed using Microsoft Excel with the frequency of GP attendance pre-
post EEP being compared.  
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Qualitative data were transcribed verbatim and thematically analysed using content analysis 
and constant comparison 23. The aim was to derive ‘saturated’ interpretive themes (when 
the researcher is no longer seeing new information) that related to any perceived impact of 
the EEP on their child’s quality of life and parental efficacy with eczema care.   
Results  
Child and parent outcome data: details of the demographic profile of those attending the 
EEP are given in Tables 3&4. Table 5 reveals highly statistically significant differences in the 
outcomes on follow up (p<0.001), other than for the CDLQI, which showed significance at 
the 5% level for the smaller (n=21) 4-16 year age group, with all measures indicating 
improvement post-intervention. Self-efficacy (PASECI) also showed an improvement in each 
domain (data not shown).  
Service impact data: 59 patient records from 23 different GP practices were reviewed from 
the 87 identified (68%). 9 (10%) patient records were unavailable due to access restrictions 
and 19 (22%) were unavailable as the patient had left the GP surgery.  18 of the 59 case 
records were further excluded because the child was under 8 months old;  these could not 
be standardised for age as follow-up was conducted 8 months pre and post EEP, so the 
sample was n=41. Almost half (n=20, 49.8%) of the total sample (n=41) were aged <2 years, 
with 29% (n=12) 2-6 years and 22% (n=9) aged over 6 years.  GP visits or practice attendance 
for an eczema related complaint, ranged from 0-13 visits per patient over the 8-month 
period pre-EEP and 0-8 visits over the 8-month period post-EEP. The total of all GP visits for 
selected participants post EEP reduced by 62% (171 pre EEP versus 65 post EEP). Pre EEP, 
27% (n=11) participants had 6 or more visits to a GP and 73% (n=30) had 5 or less visits over 
the 8-month period which includes 2 (5%) patients recording 0 visits. Post EEP, the majority 
of participants (98%, n=40) had 5 or less visits including 13 (32%) patients recording 0 visits 
and only 1 patient recording 8 visits post EEP. 
 
Qualitative data on parent-child outcomes: Table 6 summarises the themes relevant to 
disease severity, quality of life and parental self-efficacy.  
 
Several parents said their child’s eczema was mild and prior to the EEP they were not sure of 
the course’s relevance until after attendance; for example:-  
‘I really thought; is this (EEP) relevant to me? He’s growing out of it...it’s there but it’s under 
control, but then yes it is relevant because I’ve got the information...and I know what to do 
now to stop it from getting worse (Parent 5, focus group 1).’ 
Through the qualitative data parents emphasised their improved confidence from observing 
practical demonstrations of steroid cream application; for example:   
 
‘I think what I was doing was…backing off using them at all, thinking ‘oh it will get better, it 
will get better’ and it wasn’t and then I was thinking ‘oh well I’ll just put a tiny, tiny bit on.’ 
Actually, I probably wasn’t using enough so you know the whole fingertip thing was really 
helpful but to have it actually demonstrated..... I feel a hundred times more confident.’ 
Greater self-efficacy helped parents’ communication with GPs, with heightened awareness 
of how to gain the right treatments for their child. Pre-EEP parents did not always feel they 
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were listened to by doctors but after were more confident in discussing their needs and 
treatment. They felt the GP was more inclined to listen when they realised the parent had 
relevant knowledge of treatment options: 
‘One of the advantages was my GP actually listened to me after,  When I said to them that I 
came to this programme the GP actually gave me what I wanted, because he knew what I 
was talking about.’ 
The qualitative data also revealed improvements in disease-related infant-child quality of 
life, with parents believing that the EEP helped them to focus on key factors affecting their 
child.  Sleep loss was cited as a major problem for the parent and child with night-time the 
worst for scratching. The only solution for some was to sleep with their child. Triggers 
seemed worse at night when parents felt most alone and isolated:  
‘it wasn’t until I came to the group that it suddenly then sort of twigged in my mind that 
actually it’s because she’s getting hotter and she’s waking up....It’s not so much ‘what is 
wrong with her, why is she waking up?’  I now know what it is so it’s like ‘OK we can deal 
with that.’ 
All focus groups highlighted the significance of the EEP trainer’s expertise; for example: 
‘Expert support, that’s the most important one.  When I got that, then I felt like I could do it 
myself and I only had three lessons...’ 
The focus group data provided qualitative evidence consistent with the questionnaire and 
service-use data. 
Discussion  
The data revealed evidence of the effectiveness of the EEP. The statistically significant 
quantitative findings for the main outcome measures (primarily for infants as the 
predominant sample) are supported by the qualitative data; specific areas of congruence 
are the EEP alleviating quality of life impact and reducing GP attendance.  
The quality of life impact of eczema at baseline were moderate for children 24  and low for 
infants 17 , although significant improvements were observed in the pre-post change. Sleep 
loss has also been identified previously 24. The baseline severity level 16 and self-efficacy 
score were also moderate 19.  However, this may reflect that disease severity was not an 
inclusion criterion to the programme, with GPs identifying parents’ requiring support. 
Parents’ global assessment of infant eczema has been found to correlate well with IDQOL 26. 
The milder severity of patients seen in community-based studies has been highlighted as a 
factor making demonstration of effect on eczema severity difficult 26.  
It is difficult to judge from the quantitative data alone what the clinical significance of the 
outcome effects are, although fairly substantial changes in pre-post differences were 
observed for the severity (POEM) and self-efficacy measure (PASECI). However, this 
observation was also evident through the qualitative data.  
With the raised self-efficacy scores post-test and supporting qualitative themes on what 
parents valued about the EEP and their greater understanding of eczema management, it is  
hypothesised that increased parental self-efficacy in eczema care leads to improved 
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eczema-related quality of life and reduced disease severity. The dimensions of the self-
efficacy measure embrace both parental understanding to guide effective treatment use 
and ability to communicate effectively with health professionals. This concurs with another 
study which revealed parents frustration with trial and error prescribing by GPs and feeling 
‘fobbed off’ 27. Also this study and 27 highlighted that dietary matters were a key interest for 
parents.  
Although the evaluation is limited by not being a controlled study with a threat to internal 
validity, the data triangulation process enables the integration of quantitative and 
qualitative data observations to have a more rounded indicator of measured and perceived 
effects of the educational intervention.  
The measurement of child disease severity data completed by parents as a proxy measure 
was more limited in scale due to the late adoption of the POEM measure. The simple 
severity element of the IDQOL provided limited data alone, but is validated 17. However, the 
combined use of these measures appeared to be useful, indicating a likely effect of EEP on 
alleviating severity. Furthermore, the POEM tool, although ‘patient orientated,’ has good 
correlation with the CDLQI measure and global severity assessments 18. 
There were limitations to the service impact data but, although a small sample and 
uncontrolled data, there is a strong suggestion of a reduction in the frequency of 
GP/practice nurse attendance following intervention.  Also, very few of the patients for 
whom records were reviewed had been referred to a specialist or attended the emergency 
department for eczema treatment. The observation of a link between parental self-efficacy 
and improved eczema control would explain the reduction in GP appointments post EEP.  
The study background reveals there is limited robust evidence on the effectiveness of 
eczema education models especially those in which interventions can be delivered on a 
large scale with complex populations. This is the first large scale nurse-led intervention, 
where as the multidisciplinary-led models, evaluated by Staab et al 28, 29 are more extensive 
in nature. This study reinforces existing evidence that systematic educational intervention 
directed at parents (primarily) or children with eczema, can improve disease-related quality 
of life of the infant/child and alleviate disease severity9.  
This study adds a new dimension with the measurement of a process-outcome dimension of 
parental self-efficacy in eczema care. Survey findings are congruent with the in-depth focus 
group data highlighting the importance of parental ability to manage their child’s eczema. 
Many parents expressed feelings of failure prior to attending EEP. The EEP appeared to 
enable parents to more effectively manage topical treatments, particularly steroid creams, 
and communicate with their doctors to secure the right treatments.  
In contrast to other nurse-led educational interventions in managing chronic dermatoses 
the EEP was designed for delivery to a high volume of service users organised into groups. 
Multidisciplinary group educational intervention was highlighted by Staab et al 29, but this is 
the first large scale nurse-led group intervention model reported. Other nurse-led studies30, 
were one to one interventions. One nurse-led group eczema workshop study demonstrated 
improvement in eczema severity but did not evaluate quality of life 32. Smaller scale piloted 
nurse-led group educational interventions with adults with psoriasis have been reported as 
showing promise33. 
EEP BJD RESUB April 2013(2) 
 
7 
 
This study provides a useful foundation by providing extensive preliminary data examining 
the feasibility of an original parent group educational intervention programme, led by 
specialist nurses and delivered in a challenging population by virtue of its deprivation level, 
population mobility and ethnic variation. The educational approach could be considered 
what the Medical Research Council refer to as a ‘complex intervention’ whose development 
has been consistent with the call to  gather preliminary data through recruitment, tool 
testing, prior exploratory qualitative work and quantitative evaluation34.  
 
Conclusions 
This rigorous  service evaluation provides statistically significant pre-test post-test and 
saturated qualitative data which points to the value and effectiveness of the EEP, a major 
new eczema support programme. The intervention is transferable and the results are 
generalizable to other ethnically diverse child eczema populations within metropolitan areas 
in Britain. As such it contributes to the limited evidence based on structured community 
based nurse-led education targeted at parents of children with eczema. The model’s 
feasibility has been established, although this requires education to be led by specialist 
dermatology nurses. The study provides a guide to service commissioners on the value of 
such nurse-led support for children with the common condition of eczema. The hypothesis 
emerging from the study is that increased parental self-efficacy in eczema care leads to 
improved eczema-related quality of life and potentially disease severity. This is worthy of 
robust testing through a multi-centred randomised controlled trials both in the UK and 
overseas and involving the full range of socio-economic groups.  
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Table 1: Eczema Education Programme curriculum topics, rationale for inclusion, 
evidence- theory base and teaching methods 
 
Subject and rationale  Evidence / theory base Teaching method 
WHAT IS ECZEMA? 
Knowledge to support 
learning about management 
strategies and establish 
realistic treatment 
expectations 
NICE guidance 
 
Trainer led discussion 
TRIGGER FACTORS 
To empower parents to take 
positive action in avoiding 
triggers where possible 
NICE guidance 
 
Trainer led discussion 
ECZEMA TREATMENT 
The key to managing eczema 
successfully is the use of 
topical treatments 
 
NICE guidance 
Self – efficacy theory 
Practical demonstrations on 
application of topical 
treatments. Variety of 
emollients to see, touch and 
feel 
TREATMENT PLAN 
To support modelling of 
positive new behaviours 
through development of 
treatment plan 
Interactive learning 
Self-efficacy theory 
Completion of individual 
treatment plan with support 
from trainer 
FURTHER TREATMENTS 
To provide information and 
reassurance to parents with 
children with more severe or 
recalcitrant disease of other 
possible therapies.  
To understand when to seek 
Self- efficacy theory Trainer led discussion 
View, touch, feel garments 
and bandages 
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advice of specialist. 
COPING 
Acknowledge the impact of 
caring for a child with 
eczema can be challenging. 
Focus is on practical 
strategies to find on-going 
support  
Self – efficacy theory Trainer led discussion. Group 
work and problem solving on 
themes identified as difficult 
to cope with.   
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Table 2: An overview of measurement tools used for the outcome measures for children 0-
16 years old with eczema undertaking the Eczema Education Programme, Lambeth 2009-
11 
Key outcomes  Quantitative measurement tools 
Child /Infant 
disease-related 
quality of life  
Children’s Dermatology Life Quality Index, CDLQI16: for children aged 4-
16 years (0-30 score) (13) (or) Infant’s Dermatitis Quality of Life Index, 
IDQOL17: for infants i.e. child < 4 years (0-30 score). 
Disease 
(eczema) 
severity  
1) Patient Orientated Eczema Measure, POEM18: parent rating of their 
child’s eczema severity data (proxy measure).  A 7-item 0-28 score 
capturing the frequency of eczema symptoms deemed valid and 
reliable. Steering Group recommended using POEM from October 
2010.  The sole prior measure of severity in the IDQOL tool is valid16 but 
limited in scope. 2) Dermatitis severity scale is also included as a simple 
measure within IDQOL.  
Parental self-
efficacy in 
eczema care 
 
Parental Self-efficacy in Eczema Care Index, PASECI: a 40-item 
questionnaire 19 is an intermediate outcome- measuring the parents’ 
belief in their ability to manage their child’s eczema. Only the 37 items 
that related to infants were used. Perceived self-efficacy is an 
individual’s beliefs in their ability to achieve specific attainments20. Low 
self-efficacy will negatively impact on the parent’s management of 
eczema and their motivation to follow treatment plans. For each item, 
parents rated their self-efficacy on a scale of 0-10. Domains measured: 
1) managing medication; 2) managing eczema and symptoms; 3) 
communicating with healthcare professionals; 4) managing personal 
challenges caring for a child with eczema. This measure underwent 
various stages of development; prototypes were rigorously tested for 
face/content validity. Its development and reliability analysis will be 
reported elsewhere. 
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Table 3. Age breakdown of referrals to the Eczema Education Programme, Lambeth 2009-
2011  
Age  Percentage of children  
<1 year  11% 
1-2 years  25% 
2-5 years  34% 
5-9 years 18% 
10-14 years  9% 
15-16 years 2% 
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Table 4. The ethnicity profile of Eczema Education programme, Lambeth 2009-11 
 
Ethnicity  Percentage of children 
Asian Chinese 1% 
Asian or Asian British 3% 
Other  3% 
Mixed  5% 
Black African or Caribbean  23% 
White British (incl Irish and other) 27% 
Not stated 38% 
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Table 5: Median and inter-quartile range (IQR) for Infant Dermatitis Quality of Life  
(IDQOL) index, Children’s Dermatology Life Quality Index (CDLQI), disease severity (Patient 
Orientated Eczema Measure (POEM), and dermatitis severity- IDQOL element), and 
Parental Self-Efficacy with Eczema Care Index (PASECI) for children aged 0-16 years pre 
and post the Eczema Education Programme, Lambeth 2009-2011 
Outcome Pre-intervention 
median (IQR) 
Post-
intervention 
median (IQR) 
Median (IQR) 
of pre/post 
difference 
p-
value 
IDQOL for <4 year olds  
(n=116) 
 
7.0 
(3.0 - 11.0) 
3.0 
(1.0 - 6.0) 
2.0 
(-1.0 - 6.0) 
<0.001 
CDLQI for 4-16 year olds  
(n=21) 
 
9.0 
(6.5 - 15.5) 
5.0 
(2.5 - 11.5) 
3.0 
(0.0 – 8.0) 
0.027 
POEM  
(n=45) 
 
15.0 
(9.0 – 20.0) 
5.0 
(2.0 – 10.0) 
7.0 
(0.0-13.0) 
<0.001 
Dermatitis severity (IDQOL) 
(n=113) 
 
2.0 
(1.0 – 3.0) 
1.0 
(1.0 – 2.0) 
0.0 
(0.0 – 1.0) 
<0.001 
PASECI  
(n=100) 
 
24.5 
(17. 8– 30.4) 
31.4 
(28.1 – 34.4) 
5.6 
(1.9 – 11.1) 
<0.001 
Post-intervention scores were subtracted from the pre-intervention scores except for 
PASECI where pre-scores were subtracted from the post-intervention score because a 
higher score indicated higher self-efficacy; PASECI results divided by 10 to put on a more 
meaningful 0-37 scale.  Medians, inter-quartile ranges (IQRs) and p-values based on the Sign 
test are presented since the data were treated as ordinal but findings were consistent when 
using paired t-tests.  
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Table 6: Summary of qualitative data themes and categories related to parent-child 
outcomes arising from the parent focus groups to evaluate the Eczema Education 
Programme in Lambeth 2009-10  
Themes Categories 
1.Improvements in the experience of living 
with eczema 
Perceived improvement in child quality of life and 
parental quality of life 
Feeling less isolated 
Sleep problems persist but parent feels more in 
control.  
2.Increased confidence in communication 
with health professionals 
Feeling more confident talking to doctors 
Realising what the gap is in General Practitioners’ 
(GP) responses 
Recognising conflicting and/or inconsistent advice 
Getting the right treatment 
3.Perceived reduction in use of health 
services 
The parents felt that they were making fewer 
visits to the GP after attending EEP and that they 
were able to gain the information or treatment 
that they needed 
 
